Watson announced that it has received approval from the FDA for Next Choice One Dose (levonorgestrel tablets), the generic version of Teva‘s Plan B One-Step.

Plan B One-Step is a progestin-only emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. It alters the cervical mucus, exerts a progestational effect on the endometrium, interfering with implantation, and, for some, suppresses ovulation.

Next Choice One Dose package contains two 0.75mg tablets and it is available behind the pharmacy counter and sold under a licensed pharmacist’s supervision. Women <16 years of age younger require a prescription.

For more information call (866) 9-WATSON or visit www.mynextchoice.com.